Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 390

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 390
---
937,278)
  
    Issuance of common stock, net 
     268,025  
     -  
     910,000  
     -  
     910,000 
  
    Debt conversion to common stock 
     1,512,478  
     -  
     10,587,346  
     -  
     10,587,346 
  
    Shares added for fractional shares pursuant to reverse stock split 
     42  
     -  
     -  
     -  
     - 
  
    Issuance of Warrants 
     -  
     -  
     5,950,000  
     -  
     5,950,000 
  
    Net loss 
     -  
     -  
     -  
     (13,071,864) 
     (13,071,864)
  
    Balances, December 31, 2023 
     28,609,814  
     -  
     17,502,346  
     (14,064,142) 
     3,438,204 
  
    Balances 
     28,609,814  
     -  
     17,502,346  
     (14,064,142) 
     3,438,204 

    Issuance of common stock, net 
     1,142,857  
     -  
     6,832,973  
     -  
     6,832,973 
  
    Exercise of Warrants 
     10,000  
     -  
     37,300  
     -  
     37,300 
  
    Stock compensation 
        
     -  
     6,867,276  
     -  
     6,867,276 
  
    Net loss 
     -  
     -  
     -  
     (16,532,716) 
     (16,532,716)
  
    Balances, December 31, 2024 
     29,762,671  
    $-  
    $31,239,895  
    $(30,596,858) 
    $643